AXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering Patients

AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has begun pharmacokinetic/pharmacodynamics (PK/PD) studies with its CanChew Plus® Gum, the first CBD hemp oil chewing gum,